Agenda

Return

C. 63

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	April 18, 2023

Contra

Costa

County

Subject:

Amendment to Purchase Order with Qiagen, LLC

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 04/18/2023

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Ken Carlson, District IV Supervisor
Federal D. Glover, District V Supervisor

ABSENT:

John Gioia, District I Supervisor

Contact:

Sam Ferrell, (925) 357-7483

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: April 18, 2023
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, an amendment to purchase order #24587 with Qiagen, LLC to increase the payment limit by $600,000 to a new payment limit of $790,000 to procure medical supplies including QuantiFERON products as needed for the Clinical Laboratory at Contra Costa Regional Medical Center (CCRMC), and extend the term through December 31, 2023.

FISCAL IMPACT:

Approval of this action will result in an additional $600,000 in expenditures for medical supplies including QuantiFERON products over the 26 month period between October 31, 2021 through December 31, 2023 and will be funded by Hospital Enterprise Fund I revenues.

BACKGROUND:

Qiagen, LLC has provided reagents and testing supplies to the Contra Costa County Clinical Laboratory since 2015 and supplies the Laboratory with AmniSure ROM testing products, used to test pregnant women to prevent preterm labor and to help pregnant women with the depiction of ROM (rupture of membrane). Qiagen, LLC also is the only distributor for QuantiFERON reagents and supplies for our current analyzer, Liaison XL. This Liaison analyzer and corresponding QuantiFERON reagents allow the lab a streamlined Interferon-Gamma Release (IGR) test, offering results in 24 hours, versus a normal TB skin test, requiring multiple patient visits. Qiagen, LLC products also allow for fully automated immunoassay diagnostic testing reducing unnecessary staffing and labor time.

On July 27, 2021, the Board of Supervisors approved agenda item C.57 to execute County Contract #76-753 with DiaSorin, Inc. to purchase the Liaison XL analyzer. DiaSorin, Inc., the manufacturer of the Liaison XL, which uses proprietary products to ensure accurate and validated testing. The Liaison QuantiFERON-TB Gold Plus* test was developed in a partnership between Qiagen, LLC and DiaSorin, Inc. to increase accessibility to the modern blood-based QuantiFERON technology.

On March 11, 2022, the Purchasing Agent issued purchase order #24587 with Qiagen, LLC in the amount of $190,000 for the period of October 31, 2021 through December 30, 2023.

Beginning November 17, 2022, the Clinical Lab at Contra Costa Regional Medical Center (CCRMC) took over all QuantiFERON testing, that was previously sent out to either Quest or the Public Health Lab. Due to this reason and the fact that the lab has taken on this high volume of QuantiFERON testing, additional funding is needed for Qiagen, LLC supplies.

Approval of this amendment will allow this vendor, Qiagen, LLC, to continue to provide medical supplies including QuantiFERON products through December 31, 2023.

CONSEQUENCE OF NEGATIVE ACTION:

If this action is not approved, the Clinical Laboratory at CCRMC, will not have access to this vendor's specific patient supplies and products needed to prevent preterm labor and quickly diagnose tuberculosis, which may impact patient safety and health.